Condition: Pain · Analgesia · Pregnancy · Sponsor: Inova Health Care Services
This will be a single-center, sham-controlled, 3 arms, randomized (1:1:1) prospective study in females undergoing cesarean delivery to investigate the impact of NeuroCuple™ non-pharmacological analgesic device for management of postoperative pain. The investigators hypothesize that women treated with the Neurocuple device will experience less pain and consequently require less opioid pain medication after cesarean delivery compared to women who receive standard post-surgical medication.
This description comes directly from the study's public registry record.
Antonio Saad, MD · 7037766040 · antonio.saad@inova.org
Michelle Cassidy, phD · 7037764600 · michelle.cassidy@inova.org
Always discuss trial participation with your own doctor first.
| Inova Fairfax Medical Campus | Falls Church, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07185425